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ORIGINAL ARTICLE
as mechanical heart valves due to their fluid dynamic behav-
ior and freedom from anticoagulant therapy (1). As suggested 
by the literature (2, 3) tissue valves have a larger central flow 
orifice than mechanical valves, which can result in the re-
duction of flow turbulences. The larger orifice also improves 
hemodynamic conditions and allows a decrease in transvalvu-
lar pressure drops. All these elements can lead to decreased 
blood trauma.
However, despite the widespread use of artificial heart 
valves, neither MHVs nor THVs are free from complications. 
The former show high turbulent stresses, platelet activa-
tion, endocarditis, thromboembolic events arising from clot 
formation and their subsequent detachment. On the other 
hand, bioprosthetic heart valves suffer from structural val-
vular deterioration, leaflet calcification and/or tearing, and 
short term durability (1).
Polymeric heart valves (PHVs) were developed in order to 
combine the durability of the MHVs with the hemocompatibil-
ity of the THVs. The first flexible-leaflet prosthetic heart valves 
were implanted in the 1960s but, although synthetic heart 
valves exhibit acceptable short-term mechanical properties, 
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Introduction
Nowadays, 2 major types of implantable artificial heart 
valves are available: mechanical and bioprosthetic heart 
valves. Although mechanical heart valves (MHVs) have been 
the most commonly implanted devices in the past years, 
thanks to their reliable long term durability, bioprosthetic tis-
sue heart valves (THVs) are currently implanted as frequently 
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their susceptibility to hydrolytic and oxidative biodegradation 
and subsequent mechanical failure have limited their success-
ful use (4, 5).
In recent years, advances in polymer science have given 
rise to an important new class of artificial heart valve pre-
dominantly made of polyurethane-based material, which 
shows good biocompatibility and biostability (6-9). Medical 
grade segmented polyurethane (PU) has been successfully 
applied in various cardiovascular devices. PU valves are cur-
rently effectively used in commercially available assist devices 
(10, 11), but no polymeric prostheses have proven long-term 
durability for clinical implantation so far due to the hydrolytic 
degradation of the polyurethane chain under in vivo condi-
tions (12).
More recently, the development in polymeric material 
technology, especially in nanocomposite polymerization, has 
raised interest again in fully polymeric heart valves. Kidane 
et al (13) proposed nano-modified polyurethanes as innova-
tive biostable materials capable of overcoming the well-known 
degradation issue for standard PU by the chemical function-
alization of its oxidative residuals with poly(carbonate-urea) 
segment bounded with polyhedral oligomeric silsesquiox-
anes nanoparticles (14, 15).
An alternative kind of polymer suitable for the design of 
synthetic heart valve prosthesis is offered by block nanocom-
posites. The structure of block copolymers can be tailored to 
achieve mechanical and chemical ad hoc properties starting 
from the blend of 2 or more polymers. The properties of the 
final product lie between those of the initial materials (16).
Among the possible blends, novel elastomers based on 
styrenic block copolymer have being proposed as available 
polymers for the construction of heart valve prostheses due 
to their good biocompatibility, promising mechanical proper-
ties and oxidation resistance (17-20). Indeed, commercially 
available block copolymers, such as poly(Styrene-IsoButylene-
Styrene) (SIBS; Innovia Polymers) showed superior biochemi-
cal stability (21, 22) and good fatigue response (23, 24).
To enhance long-term durability, thrombogenicity and 
hemodynamic behavior, Wang et al (25) embedded rein-
forcement polyethylene terephthalate (PET) fabric into 
poly(styrene-block-isobutylene-block-styrene) (SIBS) and 
modified the surface of these prosthetic valves with a dimy-
ristoyl phosphatidylcholine (DMPC) coat. These modified SIBS 
valves failed in animal testing because of material damage 
and calcification. To avoid these drawbacks, the properties of 
SIBS had to be improved in order to provide the structural 
integrity required for long-term use in vivo. To this purpose, 
Stasiak et al (26) used thermomechanical treatments to 
change the microstructure of styrenic block copolymers and 
consequently their mechanical behavior.
In particular, we demonstrated that a cylindrical morphol-
ogy of the microdomains may turn from isotropic to oriented 
by compression molding in die channels (20). This anisotropic 
micromorphology, if optimized, could mimic the structure-
function of anisotropic collagen in the native valve, improving 
the performance of the PHV (27).
The aim of this work is to characterize the hydrodynamic 
behavior of new PHV prototypes (Poli-Valve) fabricated via 
compression molding under continuous and pulsatile condi-
tions, in order to study the adequacy of the Poli-Valve to be 
used as an alternative to mechanical and tissue heart valves 
currently on the market.
Methods
A total of 16 new PHV prototypes (Poli-Valves) were man-
ufactured by compression molding technique from two dif-
ferent commercially available styrene block copolymers (SBC) 
obtained from Kraton™ Performance Polymers. Two groups 
of valves were investigated, each one comprising 8 valves:
• Group A: valves manufactured from poly(styrene-b-iso-
prene/butadiene-b-styrene) block copolymers with 19% 
percentage by mass (wt) polystyrene fraction.
• Group B: valves manufactured from poly(styrene-b-iso-
prene-b-styrene) block copolymers with 30% wt poly-
styrene fraction.
Both materials are linear block copolymers with narrow mo-
lecular weight distribution of about 180 kg mol-1 and 130 kg 
mol-1 for groups A and B, respectively. The different polysty-
rene fraction that characterizes the 2 materials is respon-
sible for a different stiffness of these polymers. The stiffness 
is directly related to the polymer mechanical strength, as 
reported in (19).
The mold elements (Fig. 1A) were manufactured in alumi-
num by spark erosion (Cambridge Reactor Design), based on 
a 3-dimensional geometry replicating the natural configura-
tion of trileaflet heart valves (28). Poli-valve prototypes were 
obtained by hot pressing at 150°C cuboids (approximately 
0.5 cm3) of the block copolymer initially located at the com-
missural of each of the 3 leaflets of the valve. The Poli-Valve 
geometric profile and dimensions are reported in Figures 1B 
and C. Poli-valves belonging to both Group A and Group B 
were tested in vitro under continuous and pulsatile flow to 
evaluate pressure drops and regurgitation in both conditions, 
as recommended by ISO 5840 Standard (29).
Continuous and pulsatile flow tests were performed using 
distilled water at room temperature (25°C).
Continuous tests
The experimental test bench used to evaluate Poli-Valve 
pressure drops in continuous flow conditions is shown in 
Figure 2A. The setup consisted of a reservoir, a centrifugal 
pump (BIO-MEDICUS - 550 BIOCONSOLE®; Medtronic) and 
a valve housing unit (HU) designed according to the guide-
lines of the ISO 5840 Standard. The valves were sealed with 
O-rings in the HU to avoid any leakage.
The valves were tested at flow rates ranging from 0 to 
10 L/min, with an incremental step of 0.5 L/min. Transval-
vular pressure drop was measured 3 times for each valve by 
pressure transducers (140 PC pressure sensors, Honeywell) to 
verify the repeatability of the tests.
The experimental setup for the regurgitation test com-
prised a valve HU (the same used during the continuous flow 
tests); a reservoir positioned upstream to the valve, at the 
same geodetic level to provide a constant pressure preload, 
and a reservoir placed downstream from the valve, at differ-
ent heights, to vary the backpressure acting on the valve.
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During testing, the height of the reservoir was changed 
to provide a backpressure ranging within 28 to 128 mmHg 
(5 mmHg steps). Between 2 consecutive measurements, 
backpressure was set to zero mmHg to allow the valve to re-
cover its initial configuration. The regurgitation rate at each 
backpressure was measured by using a transit-time ultra-
sound flowmeter (HT110 series, Transonic Systems).
Pulsatile tests
Based on a previous work (30), a new pulse duplicator 
was designed and built up to perform pulsatile flow tests 
(Fig. 2B). It consists of the following elements: a volumet-
ric pumping system, a ventricular chamber, an aortic valve 
housing, a systemic impedance simulator and a mitral valve 
housing.
The volumetric pumping system and the systemic im-
pedance simulator have been previously described in detail 
(30). The pumping system was driven by an electronic con-
troller allowing the setting of different flow rate waveforms 
and different frequencies. In this work, the systolic flow rate 
was replicated by the Swanson and Clark waveform (31), 
while a modified Talukder and Reul flow rate waveform (32) 
was used to reproduce the diastolic flow rate. The ventric-
ular chamber allows the simulation of both physiological 
and pathological stroke volume (SV).The ventricular cham-
ber and the pumping system are divided by a thin silicon 
membrane (thickness = 0.3 mm). This way the piston can 
be isolated and filled with distilled water to prevent dam-
age to the mechanical system, while the other elements of 
the pulse duplicator can be filled with different fluids (e.g., 
blood or fluids simulating the blood rheological properties) 
if required. The aortic and the mitral valve housing are the 
same used for the continuous flow test and are connected 
with straight tubes to the systemic impedance simulator 
and to the ventricular element respectively. Furthermore, 
this setup allows the direct visual observation of both valves 
at different time steps of the cycle.
According to the UNI EN ISO 5840 Standard, the new pulse 
duplicator reproduces the physiological pressure and flow 
waveforms (Fig. 3) (i.e., arterial peak systolic pressure ranging 
from 100 to 130 mmHg, arterial diastolic pressure from 65 
to 85 mmHg, differential pressure across closed aortic valve 
equal to 95 mmHg).
The Poli-Valves were tested at different flow rates and 
backpressures, as required by the UNI EN ISO 5840 Standard. 
Fig. 1 - (A) Aluminum die, (B) sketch and (C) picture of Poli-Valve. The dimensions are: h leaflet = 10.7~10.9 mm; h tot = 21 mm; D int = 21 mm; 
D ext = 28 mm; tissue annulus diameter (TAD) = 21 mm; thickness leaflet = 0.36~0.42 mm.
Fig. 2 - Outline of the test benches: (A) experimental setup for continuous flow tests. (B) experimental set-up for the pulsatile flow tests. The 
locations of upstream and downstream pressure and flow rate probes are shown on the sketch; the observation point from which pictures 
were taken is indicated by the eye symbol.
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Transvalvular pressure drop was measured at a constant fre-
quency (70 bpm) and variable flow rate (2, 3.5, 5 and 7 L/
min). Regurgitation volume was determined by testing each 
valve at a mean flow rate of 5 L/min at 3 different frequencies 
(45, 70, 120 bpm). At each frequency, 3 backpressures were 
tested (80, 120, 160 mmHg). Simultaneous measurements 
were recorded by using transit-time ultrasound flowme-
ter and pressure transducers located 35 mm upstream and 
105 mm downstream from the aortic valve. Transvalvular 
pressure drop, regurgitation (RG), regurgitant fraction (RF) 
mean systolic pressure difference (MSPD) and effective ori-
fice area (EOA) were calculated for each valve. Equation [1] 
was used to calculate MSPD
 ∑= = ∆MSPD pi
n
i 1
n
 Eq. [1]
where Δpi is the pressure difference across the valve in mmHg 
and n is the number of samples during the systolic phase.
Equation [2] from ISO 5840 (29) was used to calculate EOA
 =
ρ
∆
EOA
Q
51.6. p
RMS  Eq. [2]
where Δp is the mean pressure difference in mmHg, ρ is the 
density of the test fluid in grams per cubic centimetre, and 
Q
RMS
 is the root mean square of forward flow in millilitres per 
second given by Equation [3]
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where Q(t) is the instantaneous flow at time t while t
1
 and t
2
 
are time at start and end of the forward flow, respectively.
Regurgitation is given by Equation [4]
 ∫=RG Q(t) dtt
t
3
4
 Eq. [4]
where t
3
 and t
4
 are time at start and end of the backward 
flow, respectively. RF% is calculated by Equation [5]
 =RF% RG
SV
.100  Eq. [5]
Statistical analysis
Each valve has been tested for at least 15 consecutive cycles 
at each test condition. SPSS Statistics version 21 (IBM®) was 
used to perform statistical tests. All data are reported as mean ± 
standard deviation (SD). Independent-samples t-test was used 
to determine statistically significant differences between the 
groups. Significance level for the tests was chosen at p<0.01.
Fig. 3 - Pressure and flow tracings 
acquired during a pulsatile test. The 
frame (A) reports the systolic pres-
sure gradient over time about a 
valve of Group A and the mean sys-
tolic pressure difference (MSPD = 
7.8 mmHg). The pictures show the 
behavior of the 2 groups of valves 
(solid line Group A and dashed line 
Group B) at different instants during 
time cycle: (B) early diastole, (C) end 
of diastole and (D) systolic peak.
Poli-valve experimental characterisation604 
© 2015 The Authors. Published by Wichtig Publishing
Results
Continuous flow test
Group A showed a statistically lower (p = 3.2e-4) mean 
transvalvular pressure drop (8.36 ± 1.33 mmHg) than Group 
B (15.26 ± 1.87 mmHg) at the maximum flow rate (10 L/min) 
(Fig. 4A).
Also the mean regurgitation displayed by Group A was 
lower (175.3 ± 19 mL/min) than Group B (264 ± 26 mL/
min) (Fig. 4C), but the difference is statistically insig-
nificant (p = 0.077). The small difference in regurgitation 
between the 2 groups may be ascribed to the different 
leakage area formed during the valve closing phase 
(Fig. 4D).
Pulsatile flow test
All the tested Poli-Valves exceeded the minimum perfor-
mance requirements set by the ISO 5840 Standard (Fig. 5): all 
the 16 PHVs showed EOA>1 cm2 and a regurgitant volume <10% 
of the stroke volume (SV = 71.4 mL). The minimum perfor-
mance requirements correspond to the following pulsatile-flow 
conditions: heart rate = 70 cycles/min, simulated cardiac output 
= 5.0 L/min, SV = 71.4 mL, mean aortic pressure = 100 mmHg, 
and systolic duration = 35%.
Group A showed statistically higher EOA (1.45 ± 0.21 cm2) 
than Group B (1.21 ± 0.12 cm2) (p = 2.29e-4).
Mean regurgitation volume was comparable between the 
2 groups (7.13 ± 1.33% of Group A vs. 6.60 ± 0.94% of Group 
B) (p>0.05).
Fig. 4 - Results of continuous flow test: 
(A) comparison of transvalvular pressure 
drops between the 2 groups of valves 
(data are reported as mean among 8 
valves ± SD). (B) Pictures of 2 Poli-Valves 
(top valve from Group A; bottom valve 
from Group B), at 2 different flowrates 
(0 l/min on the left and 10 l/min on the 
right). (C) Comparison of regurgitation be-
tween the 2 groups (data are reported as 
mean among 8 valves ± SD). (D) Pictures 
of 2 Poli-Valves (top valve from Group 
A; bottom valve from Group B) during 
static regurgitation tests, at 2 different 
backpressures (28 mmHg on the left and 
128 mmHg on the right).
Fig. 5 - EOA (A) and regurgitation (B) (% 
stroke volume) for the 2 groups of valves, 
during pulsatile tests conditions: rate = 
70 cycle/min, cardiac output = 5.0 l/min, 
mean aortic pressure 100 mmHg and sys-
tolic duration = 35%. The horizontal lines 
indicate the ISO 5840 specifications for 
the same pulsatile flow condition.
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The tests showed that the MSPD recorded in Group A 
was statistically lower (12.20 ± 1.41 mmHg) than in Group B 
(17.09 ± 3.39 mmHg) (p = 0.0019).
Also the maximum transvalvular pressure drops were sta-
tistically different (p = 3.3e-05) between Group A and Group B. 
Group A showed a maximum pressure drop equal to 30.09 ± 
4.7 mmHg, while in Group B it was 43.98 ± 4.52 mmHg.
Discussion
Steady state and pulsatile hydrodynamic tests were per-
formed to acquire information and indicators on the fluid 
mechanical behavior of Poli-Valves manufactured from block 
copolymers having different polystyrene content. The results 
from continuous and pulsatile flow tests demonstrated that 
the transvalvular pressure drop is related to the stiffness of 
the polymer, which increases with polystyrene mass percent-
age in the material (Figs. 4A and 5A).
Differences between Group A and Group B for both EOA 
and mean transvalvular pressure drops are statistically sig-
nificant as demonstrated by independent-sample t-test. 
These differences can be explained by the higher mechanical 
strength of the copolymer that constitutes the valves belong-
ing to Group B if compared to the material constituting valves 
belonging to Group A. As a matter of fact, keeping constant all 
the other conditions, a higher material stiffness is responsible 
for a smaller leaflet deformation during the systolic phase, 
and consequently for a reduced valve opening.
This result can be ascribed to the reduced leaflet defor-
mation obtained during the systolic phase in the valves be-
longing to Group B; in fact, the higher polystyrene weight 
fraction characterizing the polymer in these valves induces 
stiffer leaflet behavior thus resulting in a lower valve opening.
Poli-valves showed good opening and closing performanc-
es (Fig. 3) mimicking the behavior of natural heart valves.
The regurgitation in the continuous tests is lower in Group 
A than in Group B; inversely for the pulsatile tests, the regur-
gitation is lower in Group B than in Group A. However, in both 
tests the difference is statistically insignificant between the 
2 groups.
All the 16 Poli-Valve prototypes meet the minimum re-
quirements specified in the ISO 5840 Standard, both in terms 
of regurgitation and EOA (Fig. 5), demonstrating their effec-
tiveness. However, the experimental tests performed in this 
Fig. 6 - Comparison of the Poli-Valve 
hydrodynamic performances (EOA 
left and Regurgitation right) with 
literature data (33, 34) for tissue 
and mechanical heart valves at the 
following pulsatile flow condition: 
heart rate = 70 cycle/min, simulated 
cardiac output = 5.0 l/min, mean aor-
tic pressure 100 mmHg and systolic 
duration = 35%.
study prove that the valves belonging to Group A show better 
behavior in terms of EOA and mean pressure drops, probably 
due to the lower stiffness of the leaflets, which allows a wider 
opening.
The better performances displayed by the valves belong-
ing to Group A suggest that block copolymers having lower 
than a 30% styrene fraction should be chosen for Poli-Valve 
manufacturing.
The fluid dynamic behavior displayed by the 2 groups of 
Poli-Valves tested in this study were compared (Fig. 6) with 
literature data for commercial heart valve prostheses hav-
ing the same tissue annulus diameter (TAD) as Poli-Valves: 5 
mechanical (33) and 5 biological (34). Both EOA and regur-
gitation of mechanical and tissue heart valve prostheses are 
comparable with the data obtained for Poli-Valves. Mechani-
cal heart valves show the highest mean total regurgitant vol-
ume (ranging from 6.08 ± 1.23% to 10.78 ± 1.53%) and EOA 
(from 1.43 ± 0.11 cm2 to 1.90 ± 0.10 cm2) while tissue valves 
show the best performances in terms of mean regurgitation 
(from 3.86 ± 0.85% to 17.96 ± 1.26%). The results of this com-
parison show that the hydrodynamic behavior of Poli-Valves 
may make them a valid alternative to the valve prostheses 
currently available on the market (Fig. 6).
The durability of the Poli-Valve not only depends on the 
mechanical properties of the valve materials but also de-
pends on the manufacturing technique and on the stress 
distribution in the material. However, the hydrodynamic as-
sessment presented in this paper, together with the positive 
results of the durability tests, would make a fully polymeric 
prosthetic heart valve based on polystyrene block copolymer, 
as is Poli-Valve, an attractive alternative to the mechanical 
and biomorphic valves currently used.
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